SCHEMBL6530876

SCHEMBL6530876

COc1ccc(Sc2nc(Nc3cccc(F)c3)nc(N(Cc3ccco3)C(=O)[C@@H](N)CC(C)C)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.38
MAPK1 P28482 3/20 0.38
BLM P54132 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
PKM P14618 2/20 0.36
ALDH1A1 P00352 4/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 3/20 0.35
TSHR P16473 4/20 0.35
USP2 O75604 1/20 0.35
THRB P10828 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
EGFR P00533 1/20 0.34
HPGD P15428 1/20 0.34
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513229 0.88 ALDH1A1 (0.35) MAPTMAPK1BLMTDP1PKM
SCHEMBL6531461 0.88 EGFR (0.39) MAPTALDH1A1POLBL3MBTL1MEN1
SCHEMBL6529551 0.87 CHRNA7 (0.35) MAPTMAPK1ALDH1A1POLBKDM4E
SCHEMBL6528181 0.85 TBK1 (0.35) MAPTMAPK1ALDH1A1POLBL3MBTL1
SCHEMBL6528749 0.84 MEN1 (0.37) MAPTMAPK1ALDH1A1POLBL3MBTL1
SCHEMBL6529648 0.83 PDPK1 (0.41) MAPK1POLBTSHRUSP2MEN1
SCHEMBL6528784 0.83 GALR2 (0.37) POLB
SCHEMBL6528279 0.82 GALR2 (0.38)
SCHEMBL6533478 0.82 ITK (0.36) MAPTALDH1A1POLBSMN1; SMN2RAB9A
SCHEMBL6530216 0.80 NPC1 (0.38) MAPK1ALDH1A1POLBSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed